Stocks Near Their 52-Week High — Performance View · Biological Products, (No Diagnostic Substances)
31 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — momentum/breakout candidates, largest first. Performance columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–31 of 31
| AMGN | Amgen | +1.66% | +8.95% | +35.32% | +17.82% | +54.39% | +35.50% | 1.7% | 2.0% | 0.73 | 94K | 444.20 | +0.31% | 69K |
| GILD | Gilead Sciences | +1.59% | +14.74% | +18.53% | +2.29% | +33.84% | +24.38% | 2.5% | 2.4% | 0.64 | 292K | 151.21 | +1.09% | 186K |
| RVMD | Revolution Medicines, Inc. | -5.05% | +6.99% | +35.64% | +111.45% | +430.02% | +166.77% | 4.0% | 3.6% | 0.60 | 120K | 210.79 | +0.76% | 72K |
| BIIB | Biogen | +1.43% | +8.65% | +14.26% | +19.36% | +58.52% | +26.26% | 2.3% | 2.3% | 0.52 | 62K | 224.49 | +0.78% | 32K |
| EXEL | Exelixis, Inc. | +7.05% | +4.22% | +12.64% | +43.18% | +60.00% | +35.69% | 3.0% | 3.1% | 0.99 | 117K | 59.13 | +1.00% | 116K |
| HALO | Halozyme Therapeutics, Inc. | +3.57% | +32.52% | +54.67% | +64.39% | +47.96% | +57.51% | 2.4% | 3.0% | 0.86 | 105K | 110.73 | +1.01% | 90K |
| TECH | Bio-Techne | -0.01% | +0.64% | +36.09% | +29.76% | +35.83% | +21.43% | 0.6% | 2.1% | 0.50 | 246K | 72.46 | +0.21% | 124K |
| KRYS | Krystal Biotech, Inc. | +3.84% | +14.03% | +20.77% | +42.69% | +147.26% | +50.56% | 2.9% | 2.7% | 0.75 | 19K | 371.35 | +0.58% | 14K |
| APGE | Apogee Therapeutics, Inc. | +0.11% | +0.69% | +60.62% | +86.81% | +256.69% | +78.37% | 0.0% | 0.1% | 0.65 | 137K | 135.08 | +0.04% | 89K |
| KYMR | Kymera Therapeutics, Inc. | -2.41% | +11.12% | +57.10% | +40.30% | +170.93% | +61.09% | 4.7% | 4.7% | 0.66 | 60K | 117.15 | -1.24% | 40K |
| PCVX | Vaxcyte, Inc. | +0.11% | +9.50% | +25.66% | +5.16% | +90.72% | +31.57% | 3.5% | 4.4% | 0.63 | 68K | 61.22 | -0.62% | 43K |
| SRRK | Scholar Rock Holding Corp | -5.60% | +16.68% | +23.33% | +21.14% | +62.54% | +30.68% | 3.3% | 4.8% | 0.60 | 80K | 55.91 | -0.42% | 48K |
| CGON | Cg Oncology, Inc. | -5.95% | +2.74% | +32.48% | +23.15% | +158.74% | +77.67% | 4.7% | 4.3% | 0.62 | 49K | 74.31 | -0.41% | 31K |
| IOVA | Iovance Biotherapeutics, Inc. | +6.41% | +103.70% | +100.00% | +91.30% | +298.19% | +249.21% | 4.4% | 8.5% | 0.78 | 818K | 8.80 | +2.09% | 641K |
| ADPT | Adaptive Biotechnologies Corp | -7.04% | -0.12% | +35.71% | +54.29% | +91.28% | +54.53% | 4.6% | 4.1% | 0.59 | 182K | 24.57 | -0.34% | 108K |
| TARS | Tarsus Pharmaceuticals, Inc. | +15.52% | +35.78% | +37.66% | +11.00% | +44.08% | +3.13% | 7.5% | 5.7% | 0.63 | 68K | 83.12 | +0.41% | 43K |
| BCRX | Biocryst Pharmaceuticals Inc | +2.33% | +11.29% | +19.24% | +19.10% | +21.76% | +34.76% | 3.0% | 4.3% | 0.53 | 286K | 10.10 | -0.79% | 151K |
| REPL | Replimune Group, Inc. | -2.08% | +29.82% | +54.50% | +116.74% | +158.98% | +71.69% | 4.6% | 7.3% | 0.23 | 219K | 15.28 | -4.32% | 50K |
| CGEM | Cullinan Therapeutics, Inc. | -1.77% | +25.84% | +53.46% | +41.87% | +187.05% | +118.65% | 4.0% | 6.2% | 0.37 | 51K | 22.16 | -0.81% | 19K |
| ODTX | Odyssey Therapeutics, Inc. | +1.17% | +26.20% | +54.42% | — | — | +61.31% | 6.8% | 7.3% | 0.78 | 14K | 26.38 | -0.90% | 11K |
| ATTO | Attovia Therapeutics, Inc. | +23.14% | +22.69% | — | — | — | +19.37% | 10.7% | 10.0% | 0.60 | 39K | 25.33 | +3.56% | 23K |
| SLDB | Solid Biosciences Inc. | +2.86% | +19.29% | +43.63% | +85.91% | +80.59% | +90.15% | 4.6% | 5.6% | 0.79 | 91K | 10.42 | +1.36% | 71K |
| CADL | Candel Therapeutics, Inc. | -5.78% | +23.90% | +39.81% | +167.22% | +153.62% | +138.67% | 4.5% | 5.5% | 0.39 | 75K | 12.96 | -1.67% | 30K |
| AGEN | AGENUS INC | +4.97% | +3.52% | +142.77% | +181.85% | +92.74% | +154.80% | 5.0% | 7.7% | 0.29 | 130K | 8.23 | +1.86% | 37K |
| IKT | Inhibikase Therapeutics, Inc. | +1.21% | +4.58% | +51.20% | +32.11% | +45.93% | +28.72% | 5.4% | 4.1% | 0.70 | 66K | 2.51 | +0.40% | 46K |
| ACOG | Alpha Cognition Inc. | -5.50% | +7.54% | +53.85% | +59.72% | +12.06% | +41.32% | 4.5% | 5.5% | 1.10 | 4K | 9.20 | -1.23% | 4K |
| INMB | Inmune Bio, Inc. | -5.20% | +20.95% | +67.65% | +80.24% | +15.15% | +48.53% | 4.5% | 4.9% | 0.32 | 28K | 2.28 | -3.39% | 9K |
| CRDL | Cardiol Therapeutics Inc. | +4.61% | +60.22% | +85.78% | +114.43% | +96.80% | +117.35% | 7.0% | 7.2% | 1.26 | 52K | 2.15 | -0.23% | 66K |
| ARGX | Argenx Se | -0.56% | +21.33% | +25.00% | +44.76% | +45.70% | +25.38% | 2.5% | 2.6% | 0.25 | 32K | 1053.32 | -0.21% | 8K |
| IMCR | Immunocore Holdings Plc | +2.35% | +13.17% | +31.20% | +17.70% | +6.89% | +11.63% | 3.8% | 3.3% | 0.42 | 37K | 37.64 | +0.90% | 16K |
| FENC | FENNEC PHARMACEUTICALS INC. | +6.45% | +19.14% | +36.90% | +57.93% | +41.86% | +62.86% | 4.9% | 5.2% | 0.70 | 12K | 12.54 | +1.70% | 9K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.